Bayer Logo Bayer Logo Bayer Logo

Kyleena® Dosing and Efficacy

Women want a low-dose birth control option

Talk to your appropriate patients about Kyleena: a small, low-hormone, 5-year intrauterine device (IUD)1

IN AN ONLINE SURVEY OF 1000 WOMEN CONSIDERING HORMONAL BIRTH CONTROL2:

50% OF WOMEN (N=500) SAID THEY WERE OPEN TO USING A HORMONAL IUD

Survey respondents (N=1000) were asked to rate their level of agreement on statements regarding hormonal IUDs on a 7-point scale, with 1 representing “Completely Disagree” and 7 representing “Completely Agree.” Results captured 5 and above.

67% OF WOMEN (N=502) SAID THEY WOULD LIKE TO HAVE A LOW-DOSE OPTION

Survey respondents (N=1000) were asked “When considering a birth control method such as an IUD, do you want a low-dose hormonal option?” Respondents responded using a 7-point scale, with 1 representing “Not At All” and 7 representing “Very Much So.” Results captured 5 and above.

The survey conducted by Bayer in September 2019 included women aged 18-44 who were currently taking or considering taking hormonal prescription birth control in the next 12 months.

Kyleena acts locally and provides low hormone levels

Comparison of simulated typical serum LNG concentrations3*

Graph showing comparison of simulated typical serum LNG concentrations

Kyleena provides low daily release rates1

  KYLEENA
(levonorgestrel-releasing
intrauterine system) 19.5 mg
Initial Release Rate 17.5 mcg/day after 24 days1
After Year 1 9.8 mcg/day1
Avg in Vivo Release Rate 9.0 mcg/day over 5 years1

LNG=levonorgestrel.

High contraceptive efficacy maintained over 5 years1

Kyleena is a low-dose 5-year IUD1

98.6% CUMULATIVE EFFICACY OVER 5 YEARS

99.8% EFFICACY AT YEAR 1

>99% EFFICACY FOR EACH YEAR OF USE

The efficacy of Kyleena over 5 years was studied in 1452 parous and nulliparous women aged 18-35.

 

Year 1: Pearl Index of 0.16; 95% upper confidence limit (CL) of 0.58; cumulative 5-year pregnancy rate, based on 13 pregnancies, estimated by the Kaplan-Meier method was 1.45%; 95% upper CL of 2.53%. 

Request a Rep

Stay up to date with clinical information and virtual trainings for Kyleena.

 

See how Kyleena impacts bleeding

Know what patients may expect in the first 3 to 6 months and up to 5 years of use.

 

A non-daily contraception option

Learn more about Kyleena as a non-daily contraception option.